Morepen Laboratories moves up on the BSE
Morepen Laboratories is currently trading at Rs. 88.76, up by 0.39 points or 0.44% from its previous closing of Rs. 88.37 on the BSE.
The scrip opened at Rs. 88.90 and has touched a high and low of Rs. 91.57 and Rs. 88.55 respectively. So far 474737 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 100.80 on 10-Sep-2024 and a 52 week low of Rs. 38.56 on 13-Mar-2024.
Last one week high and low of the scrip stood at Rs. 91.57 and Rs. 84.78 respectively. The current market cap of the company is Rs. 4864.18 crore.
The promoters holding in the company stood at 35.65%, while Institutions and Non-Institutions held 3.79% and 60.56% respectively.
Morepen Laboratories’ wholly owned subsidiary -- Dr. Morepen has introduced LightLife, a 360-degree holistic weight management program designed for modern lifestyles. At its core, LightLife combines award-winning Slimbiome from the UK and Intelicaps Probiotics from Belgium - ingredients celebrated globally for their clinical efficacy in managing weight. These formulations curb cravings, promote fullness, and enhance gut health while eliminating the harmful effects often associated with extreme weight-loss tricks and fads that promise quick fixes but do more harm than good.
The program offers Pre-meal Nutrition Drinks and On-the-Go Meal, providing easy, convenient solutions that match your fast-paced lifestyle. Complemented by a state-of-the-art mobile app, LightLife enables users to access live 24x7 tracking, guided diet plans, and expert-led counselling to transform their health journey. In a world where complicated diets and all-consuming regimens are the norm, LightLife stands apart as a simple, affordable option at just Rs 599, empowering people to choose a healthy lifestyle effortlessly. Both products provide science-driven solutions, helping users stay on track without requiring constant adjustments to their daily routines
Morepen Laboratories is engaged in the manufacturing and sale of APIs/ Bulk Drugs, Home Diagnostics, Formulations and OTC products.